default author photo

Willem de Koning

Erasmus University Medical Center Rotterdam - Department of Pathology Unit of Tumor Immuno-Pathology

SCHOLARLY PAPERS

1

DOWNLOADS

44

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

­­­A Multigene Circulating Biomarker to Predict the Lack of FOLFIRINOX Response after a Single Cycle in Patients with Pancreatic Ductal Adenocarcinoma (PDAC)

Number of pages: 29 Posted: 27 Oct 2022
Casper W.F. van Eijck, Willem de Koning, Fleur van der Sijde, Miranda Moskie, Bas Groot Koerkamp, Marjolein Y.V. Homs, Sjoerd H. van der Burg, C.H.J. van Eijck and Dana A.M. Mustafa
Erasmus University Rotterdam (EUR) - Department of Surgery, Erasmus University Medical Center Rotterdam - Department of Pathology Unit of Tumor Immuno-Pathology, Erasmus University Rotterdam (EUR) - Department of Surgery, Erasmus University Rotterdam (EUR) - Department of Surgery, Erasmus University Rotterdam (EUR) - Department of Surgery, Erasmus University Medical Center Rotterdam - Medical Oncology, Leiden University - Department of Medical Oncology,, Erasmus University Rotterdam (EUR) - Department of Surgery and Erasmus University Medical Center Rotterdam - Department of Pathology Unit of Tumor Immuno-Pathology
Downloads 44 (1,133,231)

Abstract:

Loading...

Pancreatic ductal adenocarcinoma (PDAC), FOLFIRINOX chemotherapy, lack of response, blood immune transcriptome, FFX-ΔGEP score, precision medicine